 Tweaking a protein expressed by most liver cancer cells has enabled scientists to make a vaccine that is exceedingly effective at preventing the disease in mice.
Alpha-Fetoprotein, or AFP – normally expressed during development and by liver cancer cells as well – has escaped attack in previous vaccine iterations because the body recognizes it as “self,” said Dr. Yukai He, immunologist at the Medical College of Georgia and Georgia Regents University Cancer Center.
Liver cancer is among the fastest-growing and deadliest cancers in the United States with a 17 percent three-year survival rate. Vaccines help direct the immune system to attack invaders by showing it a representative substance, called an antigen, that the body will recognize as foreign, in this case, AFP for liver cancer.
Read more . . .
The Latest on: Liver cancer
[google_news title=”” keyword=”Liver cancer” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Liver cancer
- Novel Combination Therapy Shows Promise for Liver Canceron May 3, 2024 at 8:42 am
A drug that targets a protein known as phosphatidylserine boosted the response rate for hepatocellular carcinoma (HCC) patients receiving immunotherapy without compromising their safety.
- AFFF MDL Bellwether Process Extended to Claims for Thyroid and Liver Cancer Caused by PFASon May 3, 2024 at 8:23 am
The court in the aqueous film-forming foams (“AFFF”) multidistrict litigation recently established a bellwether process to address personal injury claims alleging that polyfluoroalkyl substances (PFAS ...
- Combined therapy makes headway for liver canceron May 3, 2024 at 5:48 am
A drug that targets a protein known as phosphatidylserine boosted the response rate for hepatocellular carcinoma (HCC) patients receiving immunotherapy without compromising their safety, according to ...
- Biomarkers in blood to predict liver canceron May 1, 2024 at 5:29 pm
Early detection has the potential to transform treatment and outcomes in cancer care, especially for cancers like liver cancer, which is typically diagnosed at a late stage with limited options for ...
- Buford man first in Georgia to undergo new liver cancer procedureon May 1, 2024 at 5:19 pm
Jeff Reid of Buford, Georgia, became the first liver cancer patient in Georgia to undergo a new ultrasound-based procedure that uses sound waves to target and destroy tumor cells.
- Novel Blood Biomarkers Show Potential for Early Liver Cancer Diagnosison May 1, 2024 at 5:00 pm
“Liver cancer rates are rapidly increasing, and liver cancer has a high mortality rate, but if we can diagnose it early, therapeutic interventions can be potentially curative,” lead author Xinyuan ...
- Liver Cancer Screening Benefits Patients With Cirrhosis, Study Suggestson May 1, 2024 at 2:01 pm
Among more than 1,300 patients diagnosed with HCC, the median survival reached 37 months for those with screening-detected tumors compared with 19 months for those whose tumors were found incidentally ...
- Researchers identify biomarkers in blood to predict liver canceron April 30, 2024 at 5:00 pm
Early detection has the potential to transform treatment and outcomes in cancer care, especially for cancers like liver cancer, which is typically diagnosed at a late stage with limited options for ...
- Study finds targeting BET and OXPHOS causes synthetic lethality in liver canceron April 30, 2024 at 1:49 pm
Primary hepatocellular carcinoma (HCC), the major type of liver cancer, is a leading cause of worldwide cancer-related death. End-stage liver cancer patients have limited treatment options due to the ...
- EPA rule bans toxic chemical that's commonly used as paint stripper but known to cause liver canceron April 30, 2024 at 6:03 am
The Environmental Protection Agency has finalized a ban on consumer uses of methylene chloride, a chemical widely used as a paint stripper but known to cause liver cancer and other health problems ...
via Bing News
